F-18 FDG PET as an imaging tool for detecting and staging metastatic basal-cell carcinoma.
Niederkohr
Ryan D
RD
Division of Nuclear Medicine, VA Palo Alto Healthcare System, Palo Alto, California, USA. niederkohr@stanford.edu
Gamie
Sherief H
SH
D002280:Basal Cell Carcinoma / Q000000981:diagnostic imaging* / Q000473:pathology; D003937:Diagnosis, Differential; D019788:Fluorodeoxyglucose F18; D006801:Humans; D008297:Male; D008875:Middle Aged; D009362:Neoplasm Metastasis; D019275:Radiopharmaceuticals; D012878:Skin Neoplasms / Q000000981:diagnostic imaging* / Q000473:pathology; D014055:Tomography, Emission-Computed; D051598:Whole Body Imaging
D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18